Amyloidosis
Also known as: Amyloidosis, unspecified
General information only. Anpheros does not diagnose and does not recommend treatment. Talk to a doctor or pharmacist about your situation. In an emergency, call 112 (or your local emergency number).
In short
Amyloidosis occurs when abnormal proteins called amyloids build up and form deposits in organs such as the kidney and heart, which can cause them to become stiff and unable to work properly. The three main types of the condition are primary, which has no known cause; secondary, which is caused by another disease; and familial, which is passed down through genes. Symptoms vary depending on which organs are affected, and treatment aims to manage symptoms, limit protein production, or treat any underlying disease that is causing the condition.
Source: MedlinePlus, National Library of Medicine.
AI-generated summary of the sources cited on this page, checked automatically against them. Not reviewed by a clinician; not medical advice.
Codes
Description
Amyloidosis occurs when abnormal proteins called amyloids build up and form deposits. The deposits can collect in organs such as the kidney and heart. This can cause the organs to become stiff and unable to work the way they should.
There are three main types of amyloidosis:
- Primary - with no known cause
- Secondary - caused by another disease, including some types of cancer
- Familial - passed down through genes
Symptoms can vary, depending upon which organs are affected. Treatment depends on the type of amyloidosis you have. The goal is to help with symptoms and limit the production of proteins. If another disease is the cause, it needs to be treated.
Related terms in the cited sources
Medicines with an official indication for this condition
- Inotersen Treatment
In alphabetical order.
Next to it in ICD-10
- E77Glycoproteinosis, unspecified
- E78High cholesterol and other blood lipid disorders
- E84Cystic Fibrosis
- E86Dehydration (volume depletion)
- E87Fluid, electrolyte and acid-base imbalance
- F01Dementia due to cerebrovascular disease
Neighbouring codes in the classification, not a medical link.
External resources
Questions
What is the ICD-10 code for Amyloidosis?
E85 (WHO, International Classification of Diseases, 10th Revision).
What is the ICD-11 code for Amyloidosis?
5D00.Z: Amyloidosis, unspecified (WHO, ICD-11 for Mortality and Morbidity Statistics).
Sources and attribution
- ICD-11 for Mortality and Morbidity Statistics, © World Health Organization, licensed under CC BY-ND 3.0 IGO.
- Source: MedlinePlus, National Library of Medicine.
- Names other than the official source titles: Anpheros translations and plain-language names, made with AI assistance and checked automatically; the source names are in English.
- Source: European Medicines Agency (EMA) — EPAR. © European Medicines Agency.
- ICD-10 codes and titles © World Health Organization. Source: WHO, International Classification of Diseases, 10th Revision (2019).
Anpheros Search catalog 2026.10.5, published 17 October 2026. About the data →
About this page. This page brings together public information from official sources, each cited where it is used. It is not medical advice, it is not a diagnosis, and it does not tell you which treatment to take.
Treatments. Indications are quoted unchanged from official product information (European Medicines Agency, U.S. Food and Drug Administration). They describe what a medicine is approved for, not whether it is right for you. Approved uses can differ between countries. Always read the package leaflet and follow your doctor's or pharmacist's advice.
What people report. Figures marked "reported by Anpheros users" are anonymous counts from at least 20 people who agreed to share them. They show what people report, not what works, and they are not clinical evidence.
Links between terms. "May be associated with" means the link appears in a cited source. It does not mean you have that condition.
In an emergency, call 112 (or your local emergency number). Do not delay seeking medical help because of something you read here.